Home/Filings/4/0001415889-25-022227
4//SEC Filing

Ticho Barry 4

Accession 0001415889-25-022227

CIK 0001623526other

Filed

Aug 17, 8:00 PM ET

Accepted

Aug 18, 8:25 PM ET

Size

9.5 KB

Accession

0001415889-25-022227

Insider Transaction Report

Form 4
Period: 2025-08-14
Ticho Barry
CHIEF MEDICAL OFFICER
Transactions
  • Exercise/Conversion

    Common Stock

    2025-08-14+10,00026,775 total
  • Award

    Performance Stock Units

    2025-08-14+20,00020,000 total
    Exp: 2026-08-14Common Stock (20,000 underlying)
  • Exercise/Conversion

    Performance Stock Units

    2025-08-1410,00010,000 total
    Exp: 2026-08-14Common Stock (10,000 underlying)
Footnotes (3)
  • [F1]Each performance stock unit represents a right to receive one share of the Issuer's common stock.
  • [F2]This award represents a grant of restricted stock units upon the achievement of certain performance criteria as certified by the Issuer's compensation committee on the Transaction Date.
  • [F3]Half the award vests on August 14, 2025 and the remainder shall vest on August 14, 2026, subject to the reporting person's continued service to the Issuer on the relevant vesting date.

Issuer

Stoke Therapeutics, Inc.

CIK 0001623526

Entity typeother

Related Parties

1
  • filerCIK 0001780088

Filing Metadata

Form type
4
Filed
Aug 17, 8:00 PM ET
Accepted
Aug 18, 8:25 PM ET
Size
9.5 KB